Skip to content
Vastera logo

Vastera Alternatives & Competitors

12 companies similar to Vastera — Pioneering innovative treatments for cardiovascular and cancer diseases through...

Companies similar to Vastera

MAX BioPharma, Inc. logo — alternative to Vastera

MAX BioPharma, Inc.

Pioneering new treatments for severe and life-threatening illnesses through innovative sma...

Khloris Biosciences logo — alternative to Vastera

Khloris Biosciences

Pioneering medical treatment using advanced stem cell technology to address critical cardi...

SCG Cell Therapy logo — alternative to Vastera

SCG Cell Therapy

Leading the Next Wave of Biotech Breakthroughs

Genecure logo — alternative to Vastera

Genecure

Innovative gene transfer technology aiming to combat genetic disorders, infectious disease...

Rival Readout

Competing with Vastera? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
EraCal Therapeutics  logo — alternative to Vastera

EraCal Therapeutics

Towards an efficacious and well-tolerated appetite-suppressant using our innovative in-viv...

VG Life Sciences logo — alternative to Vastera

VG Life Sciences

Developing lifesaving therapies for drug-resistant cancers and autoimmune diseases through...

Pinteon Therapeutics logo — alternative to Vastera

Pinteon Therapeutics

Pioneering therapies targeting Pin1 to normalize disease processes and enhance patient out...

Corridor Pharmaceuticals, Inc. logo — alternative to Vastera

Corridor Pharmaceuticals, Inc.

Pioneering the development and commercialization of therapeutic inhibitors to combat hyper...

Yaqrit logo — alternative to Vastera

Yaqrit

The Liver Disease Company

Opsona Therapeutics logo — alternative to Vastera
Berlin Institute of Health in der Charité logo — alternative to Vastera

Berlin Institute of Health in der Charité

Aus Forschung wird Gesundheit

Panacos Pharmaceuticals logo — alternative to Vastera

Panacos Pharmaceuticals

Innovative solutions in the fight against HIV and other viral diseases using advanced smal...

About Vastera

Vastera is a biotech startup pioneering innovative treatments for cardiovascular and cancer diseases through novel redox signaling pathways. Founded by SangWon Kang, a professor at Ewha Womans University, in 2018, the company is focused on creating "first-in-class" therapies in these medical areas, leveraging research...

Business keywords

Biotech, Cardiovascular Diseases, Cancer Treatment, Redox Signaling Pathways, Innovative Therapies, Medical Research, Ewha Womans University, Biomedical Innovation, Patent Development, Healthcare Innovation, Biomedical Startups, Medical Technology, First-in-Class Therapies

Frequently Asked Questions

Companies similar to Vastera include MAX BioPharma, Inc., Khloris Biosciences, SCG Cell Therapy, Genecure, EraCal Therapeutics . They work in Biotechnology and Health Care and share Vastera's focus on innovative therapies, cancer treatment and healthcare innovation.
Bounce Watch lists 12 companies that share Vastera's industries and are closest to it in business tags, services, target customers, business model and size.
Vastera is a biotech startup pioneering innovative treatments for cardiovascular and cancer diseases through novel redox signaling pathways. Founded by SangWon Kang, a professor at Ewha Womans University, in 2018, the company is focused on creating "first-in-class" therapies in these medical areas, leveraging research...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Vastera: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Vastera on 12 Sep 2024. The 12 companies listed here were last checked between 17 Jun 2024 and 14 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout